Accueil   Agenda - News   Toutes les news EDAP TMS : UCI Health Medical Center Becomes First in the U.S. to Treat Patients Using EDAP's Technology

EDAP TMS : UCI Health Medical Center Becomes First in the U.S. to Treat Patients Using EDAP’s Technology

 

UCI Health, one of the three US medical centers to acquire EDAP's Focal One device, is a recognized leader in prostate cancer diagnosis and treatment utilizing robot-assisted and minimally invasive technologies

 

LYON, France, February 5, 2019 - EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that UCI Health (UCI) has become the first medical center in the United States to treat prostate cancer patients with Focal One, the world's most advanced high intensity focused ultrasound (HIFU) technology. UCI is one of the three medical centers in the country to acquire Focal One, which provides urologists with one of the most precise tools on the market for the targeted, non-invasive ablation of prostate cancer tissue. The outpatient procedure preserves the prostate, enabling the patient to continue to live the best quality of life possible by lowering the incidences of troubling side effects, including impotence and incontinence associated with more invasive legacy treatments such as radical prostatectomy.

 

Lire le communiqué de presse complet

En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer